
Overview
Background
Hemamali Samaratunga MBBS (Hons) LRCP (London) MRCS (UK) FRCPA, FRCPath
- Specialist Anatomical Pathologist, Managing Director, Aquesta Specialised Uropathology
- Full Professor, University of Queensland Faculty of Medicine
- Visiting Medical Officer, Greenslopes Private Hospital
Hemamali graduated with honours from the University of Sri Lanka, Colombo Medical School and completed Pathology specialty training in Queensland. She held a number of consultant posts in both hospital and private practice. In 2008 she established Aquesta Uropathology which now provides diagnostic uropathology services to the majority of urologists in Queensland and Northern New South Wales. In addition to this she maintains a large second opinion consultation practice with requests obtained from throughout Australia and from overseas.
She is active in Genitourinary Pathology research with collaborators in Australia, USA, Canada, Karolinska Institute in Sweden and the Wellington School of Medicine in New Zealand. She held the position of Secretary of the International Society of Urological Pathology from 2015 to 2019.
She was a contributor to the 2004, 2015 and 2022 World Health Organization (WHO) books on Classification of Tumours: Pathology and Genetics of Tumours of the Urinary and Male Reproductive System. She participated in the 2015 revision of the WHO Tumour Classification in Zurich, Switzerland (4th edition) as member, Prostate Tumour Panel. She was a representative of the Expert Groups formulating structured reporting protocols for the Royal College Pathologists of Australasia on kidney, testis and prostate cancer and is currently chairperson of the structured reporting protocols for Genitourinary cancer. She is also currently the Convener for the RCPA Uropathology Quality Assurance Program.
Qualifications
MBBS (HONS) LRCP (London) MRCS (UK) FRCPA FRCPath
Current UQ Appointments
Academic Title-Professor
Non-UQ Appointments
2008 - current: Specialist Anatomical Pathologist & Managing Director, Aquesta Specialized Uropathology
2015 - Current: Visiting Medical Officer, Greenslopes Private Hospital
2003 - 2021: Visiting Medical Officer, Princess Alexandra Hospital
June 2001 - Oct 2008: Specialist Anatomical Pathologist, Sullivan Nicolaides Pathology, Brisbane
1993 - 1997: Specialist Anatomical Pathologist, Royal Brisbane Hospital
1998 - 2001: Senior Anatomical Pathologist, North Brisbane Hospitals Board
Research Interests
- Granular tumour necrosis
- Diagnosis of limited adenocarcinoma on prostate needle biopsy
- Ductal adenocarcinoma of prostate
- Mucinous adenocarcinoma of prostate
- Radical prostatectomy handling and reporting
- Micropapillary urothelial cancer
- Mimics of bladder cancer
Awards and other Esteem Indicators
2017 Admitted to Fellowship of the Royal College of Pathologists, London (FRC Path) for sustained excellence in published works
2022 Awarded the Grawitz Medal of the International Society of Urological Pathology for distinguished service to the discipline of Urological Pathology
2023 Author of the publication Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: Ten year data from the TROG 03.04 RADAR Trial. Pathology 54: 49- 54, awarded the prize of
Article of the Year by the Royal College of Pathologists of Australasia.
2024 Distinguished Fellowship Award of the Royal College Pathologists of Australasia
For distinguished service to the discipline of Urological Pathology
Keywords
Pathology, Genitourinary cancer, Prostate, Kidney, Urinary tract, Testis, Penis
Availability
- Professor Hemamali Samaratunga is:
- Available for supervision
Fields of research
Research impacts
She has over 320 scientific publications and has a Google Scholar H-index of 56 with 18150 citations. To date she has authored or co-authored 28 books, 21 book chapters and 274 peer-reviewed publications. Apart from her primary research activities Professor Samaratunga actively collaborates with other research groups and is a regular contributor - often as primary or senior author to international research consortia. One notable contribution has been her involvement in the development of artificial intelligence programs for the reporting of prostate cancer. In collaborative studies involving colleagues from the Netherlands, Sweden, Australia, New Zealand and the United States she was chosen to be one of three expert pathologists to review all cases, thus setting the gold standard for the diagnosis and grading of prostate cancer. These studies have been published in highly prestigious journals as noted in her CV. Importantly in comparative studies, the AI program informed by the findings of group of three pathologists that included Professor Samaratunga, outperformed all other AI programs.
Works
Search Professor Hemamali Samaratunga’s works on UQ eSpace
1999
Conference Publication
Molecular detection of PSA, PSMA and apolipoprotein D in ejaculate and urethral washings
Gardiner, R. A., Clements, J. A., Rohde, P., Hyland, V., Samaratunga, M. L., Tilley, W. D. and Lavin, M. F. (1999). Molecular detection of PSA, PSMA and apolipoprotein D in ejaculate and urethral washings. 1999 Annual Scientific meeting of Urological Society of Austa, Adelaide, Australia, 10 March 1999. Adelaide, Australia: Urological Society of Australasia.
1999
Journal Article
Molecular detection of prostate cells ejaculate and urethral washings in men with suspected prostate cancer
Clements, J. A., Rohde, P., Allen, V., Hyland, V. J., Samaratunga, M. L., Tilley, W. D., Lavin, M. F. and Gardiner, R. A. (1999). Molecular detection of prostate cells ejaculate and urethral washings in men with suspected prostate cancer. Journal of Urology, 161 (4), 1337-1343. doi: 10.1016/S0022-5347(01)61680-X
1998
Journal Article
Experimental pyeloureterectomy and calyceal neck transection with autotransplantation and bladder advancement
Teng, HS, Hardie, IR, Samaratunga, MLTH and Gardiner, RA (1998). Experimental pyeloureterectomy and calyceal neck transection with autotransplantation and bladder advancement. British Journal of Urology, 82 (6), 877-881. doi: 10.1046/j.1464-410X.1998.00863.x
1998
Journal Article
Non-rabies Lyssavirus human encephalitis from fruit bats: Australian bat Lyssavirus (pteropid Lyssavirus) infection
Samaratunga, H, Searle, JW and Hudson, N (1998). Non-rabies Lyssavirus human encephalitis from fruit bats: Australian bat Lyssavirus (pteropid Lyssavirus) infection. Neuropathology and Applied Neurobiology, 24 (4), 331-335.
1998
Journal Article
Evaluation of myectomized partial-thickness ileum in experimental bladder augmentation
Kotlovsky, A, Sillar, D, Samaratunga, M and Gardiner, R (1998). Evaluation of myectomized partial-thickness ileum in experimental bladder augmentation. Australian and New Zealand Journal of Surgery, 68 (8), 587-591. doi: 10.1111/j.1445-2197.1998.tb02106.x
1998
Journal Article
Mesenteric panniculitis: A mimic of malignancy
McCrystal, DJ, O'Loughlin, BS and Samaratunga, H (1998). Mesenteric panniculitis: A mimic of malignancy. Australian and New Zealand Journal of Surgery, 68 (3), 237-239. doi: 10.1111/j.1445-2197.1998.tb04754.x
1997
Journal Article
Primary lymphoma of pituitary gland: A neoplasm of acquired malt?
Samaratunga, H, Perry-Keene, D and Apel, RL (1997). Primary lymphoma of pituitary gland: A neoplasm of acquired malt?. Endocrine Pathology, 8 (4), 335-341. doi: 10.1007/BF02739936
1997
Journal Article
Intussuscepted partial-thickness ileal valve in continent urinary diversion
Sillar, DB, Samaratunga, MLTH, OBrien, MF, Kotlovsky, A, Mundy, AR and Gardiner, RA (1997). Intussuscepted partial-thickness ileal valve in continent urinary diversion. European Urology, 31 (1), 102-107. doi: 10.1159/000474427
1997
Journal Article
Distribution pattern of basal cells detected by cytokeratin 34 beta E12 in primary prostatic duct adenocarcinoma
Samaratunga H. and Singh M. (1997). Distribution pattern of basal cells detected by cytokeratin 34 beta E12 in primary prostatic duct adenocarcinoma. American Journal of Surgical Pathology, 21 (4), 435-440. doi: 10.1097/00000478-199704000-00009
1997
Journal Article
Re: Malignant cytological washings from radical prostatectomy specimens: A possible mechanism for local recurrence of prostate cancer following surgical treatment of organ confined disease
Gardiner R.A., Samaratunga M.L.T.H., Rohde P., Clements J.A., Hyland V. and Lavin M.F. (1997). Re: Malignant cytological washings from radical prostatectomy specimens: A possible mechanism for local recurrence of prostate cancer following surgical treatment of organ confined disease. Journal of Urology, 158 (3 SUPPL.), 889-889. doi: 10.1016/S0022-5347(01)64358-1
1997
Journal Article
A new lyssavirus - The first endemic rabies-related virus recognized in Australia
Hooper P.T., Lunt R.A., Gould A.R., Samaratunga H., Hyatt A.D., Gleeson L.J., Rodwell B.J., Rupprecht C.E., Smith J.S. and Murray P.K. (1997). A new lyssavirus - The first endemic rabies-related virus recognized in Australia. Bulletin de l'Institut Pasteur, 95 (4), 209-218. doi: 10.1016/S0020-2452(97)83529-5
1996
Journal Article
Abnormal prostatic cells in ejaculates from men with prostatic cancer - A preliminary report
Gardiner, RA, Samaratunga, MLTH, Gwynne, RA, Clague, A, Seymour, GJ and Lavin, MF (1996). Abnormal prostatic cells in ejaculates from men with prostatic cancer - A preliminary report. British Journal of Urology, 78 (3), 414-418. doi: 10.1046/j.1464-410X.1996.00089.x
1996
Journal Article
Intravascular fasciitis: A case report and review of the literature
Samaratunga, H, Searle, J and OLoughlin, B (1996). Intravascular fasciitis: A case report and review of the literature. Pathology, 28 (1), 8-11. doi: 10.1080/00313029600169413
1996
Journal Article
Nodular fasciitis and related pseudosarcomatous lesions of soft tissues
Samaratunga, H, Searle, J and OLoughlin, B (1996). Nodular fasciitis and related pseudosarcomatous lesions of soft tissues. Australian and New Zealand Journal of Surgery, 66 (1), 22-25. doi: 10.1111/j.1445-2197.1996.tb00694.x
1995
Journal Article
Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate disease
Devine, PL, Walsh, MD, McGuckin, MA, Quin, RJ, Hohn, BG, Claque, A and Samaratunga, H (1995). Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate disease. International Journal of Biological Markers, 10 (4), 221-225. doi: 10.1177/172460089501000406
1995
Journal Article
Carcinoma in Mesonephric Remnants - Reply
Samaratunga, H (1995). Carcinoma in Mesonephric Remnants - Reply. American Journal of Surgical Pathology, 19 (10), 1218-1219.
1995
Journal Article
Prostatic-Carcinoma Metastatizing to the Testis - An Unusual Pattern of Spread
Singh, M, Samaratunga, H, Wright, C and Guandalini, I (1995). Prostatic-Carcinoma Metastatizing to the Testis - An Unusual Pattern of Spread. British Journal of Urology, 75 (6), 803-804. doi: 10.1111/j.1464-410X.1995.tb07402.x
1994
Journal Article
Squamous-Cell Carcinoma In-Situ Involving Mesonephric Remnants - a Potential Diagnostic Pitfall
Samaratunga, H, Beresford, A and Davison, A (1994). Squamous-Cell Carcinoma In-Situ Involving Mesonephric Remnants - a Potential Diagnostic Pitfall. American Journal of Surgical Pathology, 18 (12), 1265-1269. doi: 10.1097/00000478-199412000-00011
1994
Journal Article
Immunohistological Expression of P53 in Primary Pt1 Transitional-Cell Bladder-Cancer in Relation to Tumor Progression
Gardiner, RA, Walsh, MD, Allen, V, Rahman, S, Samaratunga, Mlth, Seymour, GJ and Lavin, MF (1994). Immunohistological Expression of P53 in Primary Pt1 Transitional-Cell Bladder-Cancer in Relation to Tumor Progression. British Journal of Urology, 73 (5), 526-532. doi: 10.1111/j.1464-410X.1994.tb07638.x
1994
Journal Article
Mucin Expression by Transitional-Cell Carcinomas of the Bladder
Walsh, MD, Hohn, BG, Thong, W, Devine, PL, Gardiner, RA, Samaratunga, Mlth and McGuckin, MA (1994). Mucin Expression by Transitional-Cell Carcinomas of the Bladder. British Journal of Urology, 73 (3), 256-262. doi: 10.1111/j.1464-410X.1994.tb07514.x
Supervision
Availability
- Professor Hemamali Samaratunga is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Completed supervision
-
2020
Doctor Philosophy
Exploring Resistance of Renal Cell Carcinoma to Sunitinib Therapy
Associate Advisor
Other advisors: Associate Professor David Vesey
-
2019
Doctor Philosophy
Cellular and molecular mechanisms of pancreatitis in atrophy and regeneration
Associate Advisor
Media
Enquiries
For media enquiries about Professor Hemamali Samaratunga's areas of expertise, story ideas and help finding experts, contact our Media team: